Knight Therapeutics, Inc. (GUD.TO)
9.66
0.00 (0.00%)
CAD |
TSX |
Aug 24, 16:00
Knight Therapeutics Price : 9.66 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 9.66 | 9.83 | 9.38 | 9.66 | 91321.00 |
| Aug 21, 2026 | 9.70 | 9.74 | 9.61 | 9.66 | 39093.00 |
| Aug 20, 2026 | 9.84 | 9.93 | 9.63 | 9.63 | 53620.00 |
| Aug 19, 2026 | 9.73 | 9.89 | 9.69 | 9.82 | 55011.00 |
| Aug 18, 2026 | 9.75 | 9.80 | 9.61 | 9.73 | 53272.00 |
| Aug 17, 2026 | 9.34 | 9.80 | 9.30 | 9.78 | 96071.00 |
| Aug 14, 2026 | 9.21 | 9.32 | 9.20 | 9.32 | 122188.0 |
| Aug 13, 2026 | 9.34 | 9.34 | 9.20 | 9.21 | 51843.00 |
| Aug 12, 2026 | 9.50 | 9.65 | 9.24 | 9.29 | 120680.0 |
| Aug 11, 2026 | 9.41 | 9.60 | 9.41 | 9.50 | 85929.00 |
| Aug 10, 2026 | 9.62 | 9.82 | 9.31 | 9.31 | 68423.00 |
| Aug 07, 2026 | 9.50 | 9.85 | 9.48 | 9.76 | 249851.0 |
| Aug 06, 2026 | 9.52 | 10.00 | 9.20 | 9.50 | 222367.0 |
| Aug 05, 2026 | 9.34 | 9.36 | 9.22 | 9.26 | 183840.0 |
| Aug 04, 2026 | 9.84 | 9.85 | 9.31 | 9.34 | 107447.0 |
| Jul 31, 2026 | 9.59 | 9.93 | 9.59 | 9.84 | 60276.00 |
| Jul 30, 2026 | 9.80 | 9.95 | 9.72 | 9.77 | 59622.00 |
| Jul 29, 2026 | 9.84 | 10.00 | 9.77 | 9.87 | 50134.00 |
| Jul 28, 2026 | 9.83 | 9.88 | 9.78 | 9.84 | 58709.00 |
| Jul 27, 2026 | 9.72 | 9.87 | 9.72 | 9.82 | 52009.00 |
| Jul 24, 2026 | 9.68 | 9.80 | 9.68 | 9.73 | 34040.00 |
| Jul 23, 2026 | 9.75 | 9.76 | 9.67 | 9.69 | 66976.00 |
| Jul 21, 2026 | 9.85 | 10.01 | 9.84 | 9.97 | 78881.00 |
| Jul 20, 2026 | 9.80 | 9.89 | 9.77 | 9.84 | 26679.00 |
| Jul 17, 2026 | 9.53 | 9.86 | 9.53 | 9.82 | 88325.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| HLS Therapeutics, Inc. | 3.69 |
| Bausch Health Cos., Inc. | 9.23 |
| Cipher Pharmaceuticals, Inc. | 14.10 |
| BioSyent, Inc. | 15.50 |
| Revive Therapeutics Ltd. | 0.025 |
Price Related Metrics
| PE Ratio | 64.31 |
| PS Ratio | 1.747 |
| PEG Ratio | 0.014 |
| Price to Book Value | 1.188 |
| Price to Free Cash Flow | 9.664 |
| Earnings Yield | 1.55% |
| Market Cap | 948.84M |
| PEGY Ratio | 0.014 |
| Operating PE Ratio | 36.23 |
| Normalized PE Ratio | 47.68 |